Subsequent Events - Additional Information (Details) - USD ($) $ in Millions	Jan. 14, 2022	Oct. 12, 2021	Jan. 01, 2022
Waiver and Agreement | Relief Therapeutics Holding AG
Subsequent Event [Line Items]
Proceeds from second tranche of development payments subject to new drug application		$ 5.0
Waiver and Agreement | Relief Therapeutics Holding AG | Second Development Payment
Subsequent Event [Line Items]
Proceeds from second tranche of development payments subject to new drug application		$ 5.0
Subsequent Event | Maximum | Bonus
Subsequent Event [Line Items]
Discretionary bonus pool for employees			$ 2.2
Subsequent Event | Waiver and Agreement | Relief Therapeutics Holding AG | Second Development Payment
Subsequent Event [Line Items]
Proceeds from second tranche of development payments subject to new drug application	$ 5.0
Second tranche of development payment date	Jan. 14, 2022